Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald D Alvarez

Showing results (131-140 of 211) with videos related to

Pageof 22
Sort By:
Cancer|November 7, 2003
Cervical cancer chemoprevention, vaccines, and surrogate endpoint biomarkersMichele Follen, Frank L Meyskens, Ronald D Alvarez, et al.
Gynecologic Oncology|April 10, 2012
Completed versus aborted radical hysterectomy for node-positive stage IB cervical cancer in the modern era of chemoradiation therapyAngela J Ziebarth, Haller Smith, Mary E Killian, et al.
Human Gene Therapy|May 18, 2004
Genetic replacement of the adenovirus shaft fiber reduces liver tropism in ovarian cancer gene therapyMartina Breidenbach, Daniel T Rein, Minghui Wang, et al.
Oncotarget|September 12, 2014
Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancerZachary C Dobbin, Ashwini A Katre, Adam D Steg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicityParameshwar J Mahasreshti, Manjula Kataram, Ming H Wang, et al.
Gynecologic Oncology|March 4, 2008
Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: results from a prospectively designed analysis of progression-free survivalDavid S Alberts, Christian Marth, Ronald D Alvarez, et al.
Gynecologic Oncology Reports|January 22, 2026
Impact of carboplatin desensitization therapy on progression-free survival in gynecologic cancersNikita Bastin, Halle Petrie, Marc Robinson, et al.
Gynecologic Oncology|February 17, 2007
Efficacy of anti-death receptor 5 (DR5) antibody (TRA-8) against primary human ovarian carcinoma using a novel ex vivo tissue slice modelJacob M Estes, Patsy G Oliver, J Michael Straughn, et al.
Gynecologic Oncology|April 17, 2014
Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancerRebecca C Arend, Angelina I Londoño-Joshi, Rajeev S Samant, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 23, 2014
Folate and vitamin B12 may play a critical role in lowering the HPV 16 methylation-associated risk of developing higher grades of CINChandrika J Piyathilake, Maurizio Macaluso, Michelle M Chambers, et al.
Pageof 22

Showing results (131-140 of 211) with videos related to

Sort By:
Pageof 22
Cancer|November 7, 2003
Cervical cancer chemoprevention, vaccines, and surrogate endpoint biomarkersMichele Follen, Frank L Meyskens, Ronald D Alvarez, et al.
Gynecologic Oncology|April 10, 2012
Completed versus aborted radical hysterectomy for node-positive stage IB cervical cancer in the modern era of chemoradiation therapyAngela J Ziebarth, Haller Smith, Mary E Killian, et al.
Human Gene Therapy|May 18, 2004
Genetic replacement of the adenovirus shaft fiber reduces liver tropism in ovarian cancer gene therapyMartina Breidenbach, Daniel T Rein, Minghui Wang, et al.
Oncotarget|September 12, 2014
Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancerZachary C Dobbin, Ashwini A Katre, Adam D Steg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicityParameshwar J Mahasreshti, Manjula Kataram, Ming H Wang, et al.
Gynecologic Oncology|March 4, 2008
Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: results from a prospectively designed analysis of progression-free survivalDavid S Alberts, Christian Marth, Ronald D Alvarez, et al.
Gynecologic Oncology Reports|January 22, 2026
Impact of carboplatin desensitization therapy on progression-free survival in gynecologic cancersNikita Bastin, Halle Petrie, Marc Robinson, et al.
Gynecologic Oncology|February 17, 2007
Efficacy of anti-death receptor 5 (DR5) antibody (TRA-8) against primary human ovarian carcinoma using a novel ex vivo tissue slice modelJacob M Estes, Patsy G Oliver, J Michael Straughn, et al.
Gynecologic Oncology|April 17, 2014
Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancerRebecca C Arend, Angelina I Londoño-Joshi, Rajeev S Samant, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 23, 2014
Folate and vitamin B12 may play a critical role in lowering the HPV 16 methylation-associated risk of developing higher grades of CINChandrika J Piyathilake, Maurizio Macaluso, Michelle M Chambers, et al.
Pageof 22